Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2007; 13(23): 3237-3244
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3237
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3237
Table 1 Histological scoring model
0 | No fibrosis or minimal fibrous expansion of occasional portal areas |
1 | Moderate fibrous expansion of some portal areas with short fibrous septae |
2 | Moderate fibrous expansion of most portal areas, occasional portal-to-portal bridging |
3 | None or minimal expansion of portal areas, porto-portal fibrosis, incomplete bridging nodules |
4 | Marked portal fibrosis, portal to portal fibrosis, occasional micronodules |
5 | Mild to moderate fibrous expansion in portal areas, micronodules, incomplete cirrhosis |
6 | Marked fibrosis in portal areas, macro- and micronodules with thick fibrous septae, complete cirrhosis |
- Citation: Tasci I, Mas MR, Vural SA, Deveci S, Comert B, Alcigir G, Mas N, Akay C, Bozdayi M, Yurdaydin C, Bozkaya H, Uzunalimoglu O, Isik AT, Said HM. Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis. World J Gastroenterol 2007; 13(23): 3237-3244
- URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3237.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3237